COCP
$1.03-0.06 (-5.50%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.03
Potential Upside
5%
Whystock Fair Value$1.08
Price
UndervaluedFair ValueOvervalued
Fundamentals
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. It employs structure-based technologies to create antiviral ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$14.20M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.22
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-126.11%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
5.78
Recent News
BC-Most Active Stocks
td class="col-issue">Next Technology Holding Inc.
Wall Street Set to Open Little Changed Friday Ahead of Consumer Sentiment Report
US stocks look set to open little changed in Friday's trading session ahead of consumer sentiment da